HIV/AIDS Treatment News: May 2011
- U.S. Mulls Implications of Early Use of HIV Drugs to Stop AIDS Spread (May 27, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Wider Distribution of Drugs Needed to Cut AIDS Deaths in China (May 27, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Continue HIV Treatment While Data Is Collected on Treatment as Prevention (May 27, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
Edurant (Rilpivirine): The HIV Treatment Dating Game Just Got More Interesting (May 26, 2011)
An interview with Cal Cohen, M.D.
From TheBody.com
- Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg (May 25, 2011)
From U.S. Food and Drug Administration
- The Race to Treat Hepatitis C Isn't Over: Merck's Victrelis Is First New Medicine to Get OK (May 24, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves Incivek (Telaprevir) for Hepatitis C (May 23, 2011)
From U.S. Food and Drug Administration
- Merck's Hepatitis C Drug Wins Approval in Europe (May 23, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Prevention Study Results Raise Public Health Questions About Forcing Patients Into Treatment (May 23, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- A New HIV Drug Called Edurant Gets Approved for First-Time Patients (May 20, 2011)
From Project Inform
VIEW ALL ARTICLES
|
Advertisement
|